OOIR: Observatory of International Research

Papers

(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Establishing a reasonable price for an orphan drug	47
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds	32
Status and determinants of enrollment and dropout of health insurance in Nepal: an explorative study	24
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran	21
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US	20
What makes inequality in the area of dental and oral health in developing countries? A scoping review	19
How much the Iranian government spent on disasters in the last 100 years? A critical policy analysis	19
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—2023	18
Strategies for reducing out of pocket payments in the health system: a scoping review	18
Is bed turnover rate a good metric for hospital scale efficiency? A measure of resource utilization rate for hospitals in Southeast Nigeria	18
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making	18
Health systems efficiency in Eastern Mediterranean Region: a data envelopment analysis	17
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis	17
Examination on level of scale efficiency in public hospitals in Tanzania	16
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis	16
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation	15
Household catastrophic health expenditure and its effective factors: a case of Iran	14
Level and determinants of county health system technical efficiency in Kenya: two stage data envelopment analysis	14
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma	13
Health technology assessment of medical devices: current landscape, challenges, and a way forward	13
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy	12
Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package	12
Predicting positive organizational behavior based on structural and psychological empowerment among nurses	11
Market access and value-based pricing of digital health applications in Germany	11
Some reflections on the use of inappropriate comparators in CEA	11

Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation	11
Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care	11
Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment	11
Hospital efficiency measurement in the west of Iran: data envelopment analysis and econometric approach	10
Methodological challenges surrounding QALY estimation for paediatric economic evaluation	10
Comparison of cost effectiveness between video-assisted thoracoscopic surgery (vats) and open lobectomy: a retrospective study	10
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis	10
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact	9
Cost effectiveness of outpatient lumbar discectomy	9
Factors affecting the technical efficiency of rural primary health care centers in Hamadan, Iran: data envelopment analysis and Tobit regression	9
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong	8
Cost-effectiveness of a novel smartphone application to mobilize first responders after witnessed OHCA in Belgium	8
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?	8
Neural networks and hospital length of stay: an application to support healthcare management with national benchmarks and thresholds	8
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong	8
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings	8
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases	8
Comparison of the healthcare system of Chile and Brazil: strengths, inefficiencies, and expenditures	7
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?	7
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China	7
A systemmatic literature review on indirect costs of women with breast cancer	7
Cost-effectiveness of facility-based, stand-alone and mobile-based voluntary counseling and testing for HIV in Addis Ababa, Ethiopia	7
A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt	7
Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomised controlled trial	7
Modeling the Cost-effectiveness of Esophageal Cancer Screening in China	7
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database	7
The origin of cost–benefit analysis: a comparative view of France and the United States	7
The use of evaluation methods for the overall assessment of health policy: potential and limitations	7
What are economic costs and when should they be used in health economic studies?	7
The effect of different classification of hospitals on medical expenditure from perspective of classification of hospitals framework: evidence from China	7
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey	7
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation	6
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective	6
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries	6
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China	6
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method	6
Total productivity change of Health Centers in Greece in 2016–2018: a Malmquist index data envelopment analysis application for the primary health system of Greece	6
Predictors of loss due to pharmaceutical fraud: evidence from the U.S.	6
Dynamic linkages among economic development, environmental pollution and human health in Chinese	6
The pharmaceutical practice of mask distribution by pharmacists in Taiwan’s community pharmacies under the Mask Real-Name System, in response to the COVID-19 outbreak	6
A qualitative study on patient-centered care and perceptions of nurses regarding primary healthcare facilities in Nigeria	6
Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only	6
Household preferences and willingness to pay for health insurance in Kampala City: a discrete choice experiment	6
The influence of medical insurance and social security cards on the floating population's settlement intention	6
A comprehensive framework for considering additional unintended consequences in economic evaluation	6
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial	6
Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan	6
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana	6
The health care sector in the economies of the European Union: an overview using an input–output framework	5
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China	5

Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives	5
A systematic review of the budget impact analyses for antitumor drugs of lung cancer	5
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting	5
Impact of quality certification of multidisciplinary head and neck tumor centers	5
Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach	5
Exploring physicians and patients’ perspectives for current interventions on thyroid nodules using a MCDA method	5
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China	5
Title: the impact of a pilot integrated care model on the quality and costs of inpatient care among chinese elderly: a difference-in-difference analysis of repeated cross-sectional data	5
A systematic literature review on direct and indirect costs of triple-negative breast cancer	5
Risk factors associated with postoperative complications after liver cancer resection surgery in western China	5
Changes in productivity in healthcare services in the Kingdom of Saudi Arabia	5
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting	5
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china	5